chronic periodontitis. Chronic periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The amount of clinical attachment loss is 3 mm or more The age of the patient is between 25-60 3. The patient should be systemically healthy (such as not suffering from diabetes, high blood pressure or liver problems)
Exclusion criteria
Exclusion criteria: History of periodontal treatment during the last 6 months Presence of disease or systemic conditions that interfere with wound healing. Pregnant or lactating patient smoking The patient is undergoing radiotherapy or chemotherapy Taking drugs that affect the periodontium, such as anticonvulsants, calcium channel blockers Taking blood lipid-lowering drugs that reduce Coenzyme Q10, such as statins ( lovastatin and atorvastatin) Taking vitamin A, vitamin E and Coenzyme Q10 supplements during the last three months Taking warfarin or clopidogrel because some studies indicate the interaction of Coenzyme Q10 with anticoagulant drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Probing depth. Timepoint: At the beginning of the study and 6 weeks after the start of red CoQ10 consumption. Method of measurement: Williams periodontal probe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical attachment loss. Timepoint: At the beginning of the study and 6 weeks after the start of red CoQ10 consumption. Method of measurement: Williams periodontal probe.;Bleeding on probing. Timepoint: At the beginning of the study and 6 weeks after the start of red CoQ10 consumption. Method of measurement: Williams periodontal probe. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yazd University of Medical Sciences